AI assistant
Sending…
MARZETTI CO — Director's Dealing 2012
Feb 27, 2012
31063_dirs_2012-02-27_7df54071-84b0-4ab9-8594-f0cf71785f89.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANCASTER COLONY CORP (LANC)
CIK: 0000057515
Period of Report: 2012-02-27
Reporting Person: ROSA BRUCE L (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-27 | Common Stock | F | 109 | $67.94 | Disposed | 3836 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-02-25 | Stock Appreciation Right | $39.86 | A | 12000 | Acquired | 2014-02-25 | Common Stock (4000) | Direct |
| 2010-02-24 | Stock Appreciation Right | $58.79 | A | 14000 | Acquired | 2015-02-24 | Common Stock (14000) | Direct |
| 2011-02-22 | Stock Appreciation Right | $57.78 | A | 15000 | Acquired | 2016-02-22 | Common Stock (15000) | Direct |
| 2012-02-21 | Stock Appreciation Right | $68.12 | A | 16000 | Acquired | 2017-02-21 | Common Stock (16000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 50458 | Indirect |
| Common Stock | 11026.558 | Indirect |
| Common Stock | 794.4661 | Indirect |
Footnotes
F1: Reflects ESOP allocations that had occurred as of 6/30/11.
F2: Shares contributed by Lancaster Colony Corporation as a matching contribution under Lancaster Colony Corporation's 401(k) Plan as of 6/30/11.
F3: Stock appreciation rights awarded to Mr. Rosa pursuant to the 2005 Stock Plan. The rights vest ratably over a three-year period beginning on the first anniversary of the grant date and can be exercised up to five years from the grant date.
More from MARZETTI CO
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 11
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2026
Jan 7
Director's Dealing
2025
Nov 24